Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea

• Published in: Epidemiology and health Vol. 44; p. e2022072
• Main Authors: Luu, Xuan Quy, Lee, Kyeongmin, Jun, Jae Kwan, Suh, Mina, Jung, Kyu-Won, Lim, Myong Cheol, Choi, Kui Son
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Society of Epidemiology 07.09.2022
• Subjects: cervical cancer; Cohort Studies; Early Detection of Cancer; Female; Humans; Mass Screening; Original; Papanicolaou Test; Republic of Korea - epidemiology; Retrospective Studies; survival; Uterine Cervical Neoplasms - prevention & control; Vaginal Smears; Republic of Korea; Mass screening; Survival; Cervical cancer; Papanicolaou test
• ISSN: 2092-7193; 2092-7193
• DOI: 10.4178/epih.e2022072

This study aimed to investigate the effect of cervical cancer screening by Papanicolaou (Pap) smears on the long-term survival of cervical cancer patients. We constructed a retrospective cohort of 14,903 women diagnosed with invasive cancer or carcinoma in situ in 2008 and 2009 and followed up until December 31, 2019, by using individual-level data from 3 national databases of the Korean National Cancer Screening Program, the Korean Central Cancer Registry, and death certificates. Cox proportional-hazards regression was used to investigate the effect of cervical cancer screening on mortality. In total, 12,987 out of 14,867 patients (87.4%) were alive at the end of the follow-up period (median: 10.5 years). Screened patients had a 38% lower risk of cervical cancer death than never-screened patients (hazard ratio [HR], 0.62; 95% confidence interval [CI], 0.54 to 0.70). Screening was associated with 59% and 35% lower risks of death, respectively, in screened patients with localized and regional stages. Furthermore, lower HRs among women who received screening were observed in all age groups, especially women aged 50-59 years (HR, 0.54; 95% CI, 0.42 to 0.69). The lowest HR for cervical cancer death was reported among patients screened within the past 2 years (HR, 0.54; 95% CI, 0.47 to 0.63), and the HRs increased with increasing time intervals. Pap smear screening significantly reduced the risk of cervical cancer-specific death in Korean women across all cancer stages.